Navigation Links
Nu Skin Enterprises Enters Into a Letter of Intent to Acquire LifeGen Technologies
Date:10/27/2011

he molecular level in individual organs is expected to be a key component of the intellectual property to be acquired.  

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC™ science that addresses aging at its source. The company's anti-aging products feature the new ageLOC suite of products including the ageLOC R2 nutritional supplement, ageLOC Galvanic Spa System and Galvanic Body Spa™, as well as the ageLOC Transformation daily skin care system. A global direct selling company, Nu Skin operates in 52 markets worldwide and has more than 825,000 independent distributors. Nu Skin is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

Please note: This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the company's current expectations and beliefs regarding the company's intent to acquire LifeGen Technologies, LLC; potential acquisition timing, terms and conditions; the impact of the acquisition on the company's financial results and product development efforts; the potential of ongoing research; and the company's plans and strategies. These forward-looking statements and related assumptions are based on current information and expectations regarding the potential acquisition, and are subject to risks and uncertainties, including the risk that either party may decide not to pursue the acquisition as planned; the risk that the potential acquisition may cost more and take longer t
'/>"/>

SOURCE Nu Skin Enterprises, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4
2. Sicilian word enters British genetic language
3. From sheet metal elements to host cells: DFG launches 10 new collaborative research centers
4. Tellme Enters Automotive Market
5. The first DFG research centers to be funded for another four years
6. BIO-key(R) Enters Strategic Partnership With Nlets
7. BIO-key(R) Enters Strategic Partnership With Nlets
8. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
9. Graffinity Enters into Drug Discovery Research Collaboration with Genentech
10. Oxford University Press enters publishing partnership with Infectious Diseases Society of America
11. DFG approves funding for 17 new collaborative research centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... as they,re planted may be good news for a garden. ... wild, a plant whose seeds sprouted at the first ,warm ... an insurance policy against late frosts or unexpected dry spells, ... Plants whose seeds put off sprouting until conditions are ... team of researchers working at the National Evolutionary Synthesis Center ...
(Date:4/17/2014)... peptide inhibits RSV infection , Respiratory syncytial ... respiratory tract infections, generating life-threating illness in very ... therapies are limited. RSV enters host cells through ... six-helix fusogenic bundle. Small interfering peptides that prevent ... these peptides are highly susceptible to degradation. In ...
(Date:4/17/2014)... Gauthier and Professor Luca Razzari of the nergie ... large grants from the John R. Evans Leaders ... for the acquisition of state-of-the-art biotech and nanophotonics ... grants from the Ministre de l,Enseignement suprieur, de ... Technologie (MESRST). These new laboratories will help us ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
... came from other planets. So concludes a major scientific article which ... Cosmology.com For thousands ... life. Surprisingly, most scientists and the Catholic Church are of the ... "organic soup." In the Judeo-Christian Bible, the ...
... Dental and tissue engineering researchers at Tufts University School of ... at Tufts have harnessed the pluripotency of human embryonic stem ... skin and the oral mucosa (the moist tissue that lines ... online in advance of print in Tissue Engineering Part ...
... scientists at Iowa State University,s Plant Sciences Institute has ... in plant genes much more efficient, practical and safe. ... associate scientist, and Jeffery Townsend, an assistant scientist, and ... have a huge impact on plant genetic work in ...
Cached Biology News:Life on Earth came from other planets 2Life on Earth came from other planets 3Life on Earth came from other planets 4Skin-like tissue developed from human embryonic stem cells 2Iowa State University researchers develop process for 'surgical' genetic changes 2Iowa State University researchers develop process for 'surgical' genetic changes 3
(Date:1/14/2014)... and Cardiff, UK (PRWEB) January 13, 2014 ... development leader with more than 20 years in the ... optics and photonics . Hainsey will serve as the ... to have Dr. Hainsey join SPIE as our Technology ...
(Date:1/14/2014)... January 14, 2014 During the 1600’s through ... as “The Doctor’s Plague.” In this time period, doctors did ... led, at times, to the death of vulnerable patients. In ... know that they may be unwittingly transmitting herpes viruses to ...
(Date:1/14/2014)... NC (PRWEB) January 14, 2014 BioMedomics, ... on ultra-sensitive POC diagnostic platforms and novel disease specific POC ... round of financing netting a total of $690,000. The investment ... capital in the company. This group of private investors has ...
(Date:1/14/2014)... Panama (PRWEB) January 14, 2014 ... received the county’s first clinical trial approval for ... cord-derived mesenchymal stem cells (MSC) from the Comité ... Board (IRB). , Rheumatoid Arthritis (RA) is an ...
Breaking Biology Technology:Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3BioMedomics, Inc. Closes $690K Round of Financing 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 3
... , , CALGARY, Dec. ... company developing protein pharmaceuticals in crop plants, today announced ... of its plant-produced insulin with the first injection of ... the United Kingdom (UK), will include up to 30 ...
... numerous,shareholder inquiries, CEL-SCI Corporation (NYSE Alternext US: CVM) announced,today ... manufacturing facility to,its website. The pictures can be accessed ... link "Updated Pictures of,Manufacturing Facility" in the special highlights ... is developing its cancer product Multikine(R) for approval as ...
... FRANCISCO, Calif., Dec. 3 Portola,Pharmaceuticals, a biopharmaceutical ... cardiovascular disease, inflammatory disease,and cancer, today announced that ... that inhibit spleen tyrosine kinase (Syk) and its ... at the annual meeting of the,American Society of ...
Cached Biology Technology:SemBioSys begins phase I/II trial of insulin produced in plant seeds 2SemBioSys begins phase I/II trial of insulin produced in plant seeds 3Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting 2Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting 3
...
...
...
... Sepharose High Performance, 5 ml. The ... in HiTrap Streptavidin columns for fast, ... packing into Tricorn 5/50 GL, XK ... scale purifications are required.Extremely useful for ...
Biology Products: